Skip to content

Aging-US Authors

Aging-US.net features press releases on the latest aging research, plus interviews and from the distinguished network of authors who continue to publish their research with Aging-US.

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube
  • Pinterest
  • SoundCloud
  • Reddit
  • Home
  • News

Aging-US Authors

Figure 1. Proposed mechanism showing the parallels between age-associated brain and vascular amyloidosis, with both being mediated by sEVs and affected by cellular senescence.
Aging News

Senescence and Extracellular Vesicles: Novel Partners in Vascular Amyloidosis

March 29, 2023March 30, 2023

PRESS RELEASE: A new editorial paper was published in Aging’s Volume 15, Issue 5, entitled, “Senescence and extracellular vesicles: novel partners in vascular amyloidosis.”

Read More
Figure 5. Platelet depletion increases astrocytic coverage of fibrillary amyloid plaques.
Aging News

Aging | Immune-mediated Platelet Depletion Augments Alzheimer’s Disease in Mice

February 15, 2023February 15, 2023

PRESS RELEASE: A new research paper was published on the cover of Aging’s Volume 15, Issue 3, entitled, “Immune-mediated platelet depletion augments Alzheimer’s disease neuropathological hallmarks in APP-PS1 mice.”

Read More
Figure 1. A schematic diagram of potential APOE-related mechanism of Alzheimer’s disease (AD).
Aging News

Aging | Associations of APOE ε2 and ε4 Alleles and Polygenic Profiles Comprising APOE-TOMM40-APOC1 Variants With Alzheimer’s Disease Biomarkers

January 3, 2023January 5, 2023

PRESS RELEASE: A new research paper was published on the cover of Aging’s Volume 14, Issue 24, entitled, “Associations of the APOE ε2 and ε4 alleles and polygenic profiles comprising APOE-TOMM40-APOC1 variants with Alzheimer’s disease biomarkers.”

Read More
Volume 14, Issue 24
Aging Latest Issue

Associations of the APOE ε2 and ε4 alleles and polygenic profiles comprising APOE-TOMM40-APOC1 variants with Alzheimer’s disease biomarkers

December 31, 2022December 31, 2022

Capturing the genetic architecture of Alzheimer’s disease (AD) is challenging because of the complex interplay of genetic and non-genetic factors in its etiology. It has been suggested that AD biomarkers may improve the characterization of AD pathology and its genetic architecture…

Read More
Dr. Ya-Jen Chiu
Aging News Spotlight

Behind the Study: Novel TRKB Agonists Activate TRKB and Downstream ERK and AKT Signaling

November 1, 2022November 3, 2022

Dr. Ya-Jen Chiu discusses a research paper she co-authored that was published by Aging (Aging-US) in Volume 14, Issue 18, entitled, “Novel TRKB agonists activate TRKB and downstream ERK and AKT signaling to protect Aβ-GFP SH-SY5Y cells against Aβ toxicity.”

Read More

Posts pagination

Previous 1 2 3
  • X

Copyright © 2023 Impact Journals, LLC

Impact Journals is a registered trademark of Impact Journals, LLC